Details for Patent: 11,793,812
✉ Email this page to a colleague
Which drugs does patent 11,793,812 protect, and when does it expire?
Patent 11,793,812 protects MYFEMBREE and is included in one NDA.
This patent has sixty-two patent family members in twenty-four countries.
Drugs Protected by US Patent 11,793,812
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Myovant Sciences | MYFEMBREE | estradiol; norethindrone acetate; relugolix | TABLET;ORAL | 214846-001 | May 26, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | MANAGEMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH ENDOMETRIOSIS | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,793,812
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 109759 | ⤷ Try a Trial | |||
| Argentina | 109762 | ⤷ Try a Trial | |||
| Argentina | 110636 | ⤷ Try a Trial | |||
| Australia | 2017334035 | ⤷ Try a Trial | |||
| Australia | 2017336338 | ⤷ Try a Trial | |||
| Australia | 2017336363 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
